Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different.

Similar presentations


Presentation on theme: "Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different."— Presentation transcript:

1 Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different P2Y12 inhibitors in a large observational study  Jeong Cheon Choe, Kwang Soo Cha, Jinhee Ahn, Jin Sup Park, Hye Won Lee, Jun-Hyok Oh, Jung Hyun Choi, Han Cheol Lee, Taek Jong Hong, Myung Ho Jeong  International Journal of Cardiology  Volume 274, Pages (January 2019) DOI: /j.ijcard Copyright © 2018 Elsevier B.V. Terms and Conditions

2 Fig. 1 Kaplan-Meier estimation of cumulative survival-free from MACEs (A), cardiac death (B), nonfatal MI (C), and stroke (D). CI, confidence interval; HR, hazard ratio; MACE, major adverse cardiac events; MI, myocardial infarction. International Journal of Cardiology  , 21-26DOI: ( /j.ijcard ) Copyright © 2018 Elsevier B.V. Terms and Conditions

3 Supplementary Fig. 1 Flowchart of the selection of the study population. ACS, acute coronary syndrome; DAPT, dual antiplatelet therapy; KAMIR-NIH, the Korea Acute Myocardial Infarction Registry-National Institutes of Health; PCI, percutaneous coronary intervention. International Journal of Cardiology  , 21-26DOI: ( /j.ijcard ) Copyright © 2018 Elsevier B.V. Terms and Conditions

4 Supplementary Fig. 2 Independent predictors of any bleeding (A), major bleeding (B), and minor bleeding (C). CI, confidence interval; LVEF, left ventricular ejection fraction; OR, odds ratio. International Journal of Cardiology  , 21-26DOI: ( /j.ijcard ) Copyright © 2018 Elsevier B.V. Terms and Conditions

5 Supplementary Fig. 3 Kaplan-Meier estimation of cumulative survival free from major adverse cardiac events (MACEs) and cardiac death in the ticagrelor-clopidogrel (A and B), prasugrel-clopidogrel (C and D), and ticagrelor-prasugrel-matched (E and F) cohorts. CI, confidence interval; HR, hazard ratio. International Journal of Cardiology  , 21-26DOI: ( /j.ijcard ) Copyright © 2018 Elsevier B.V. Terms and Conditions

6 Supplementary Fig. 4 Independent predictors of MACEs (A) and cardiac death (B). CI, confidence interval; CKD, chronic kidney disease; HR, hazard ratio; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac events. International Journal of Cardiology  , 21-26DOI: ( /j.ijcard ) Copyright © 2018 Elsevier B.V. Terms and Conditions

7 Supplementary Fig. 5 Subgroup analysis of major adverse cardiac events. (A) Propensity score-matched cohort. (B) Propensity score-adjusted analysis of entire cohort. CI, confidence interval; HR, hazard ratio; LVEF, left ventricular ejection fraction; STEMI, ST-elevation myocardial infarction. International Journal of Cardiology  , 21-26DOI: ( /j.ijcard ) Copyright © 2018 Elsevier B.V. Terms and Conditions


Download ppt "Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different."

Similar presentations


Ads by Google